{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:08:41Z","timestamp":1768342121537,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,6,9]],"date-time":"2003-06-09T00:00:00Z","timestamp":1055116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2003,9,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Classical Hodgkin lymphoma (HL) is characterized by the presence of Hodgkin and Reed\u2010Sternberg cells (H&amp;RS) and a prominent lymphocytic infiltration. We previously reported Hodgkin\u2010like adult T\u2010cell leukemia\/lymphoma (HL\u2010like ATLL) (new WHO classification). Various CXC and CC chemokines are expressed on H&amp;RS cells and the relationships between chemokines and the chemokine receptor (R) are thought to be important for selectivity of local immunity of Th1 and Th2 T cells. To clarify the role of T\u2010cell immunity in classical HL and Hodgkin\u2010like ATLL, we performed gene expression profiling (chemokine, chemokine R and cytokine DNA chips) in 12 cases {classical HL, 8 cases [mixed cellularity (MC) type, 4; nodular sclerosis (NS) type, 4]; Hodgkin\u2010like ATLL, 4 cases} and immunohistochemical staining in 29 cases (MC, 10; NS, 10; Hodgkin\u2010like ATLL, 9). EBV\u2010infected H&amp;RS cells were detected in 9 of 10 cases of HL MC, 5 of 9 of HL\u2010like ATLL and 2 of 10 HL NS. T\u2010cell\u2010directed chemokine thymus\u2010 and activation\u2010regulated chemokine (TARC)\u2010 and\/or macrophage\u2010derived chemokine (MDC)\u2010positive H&amp;RS cells were detected in all 20 cases of HL MC and HL NS but only in 5 of 9 cases of HL\u2010like ATLL. Interferon\u2010\u03b3\u2010inducible protein\u201010 (IP10)\u2010 and monokine induced by interferon\u2010\u03b3 (MIG)\u2010positive H&amp;RS cells were detected in all 10 HL MC but only in 5 of 10 cases of HL NS and 2 of 9 cases of HL\u2010like ATLL. However, 2 of 5 cases of HL\u2010like ATLL with EBV infection and 2 of 2 HL NS with EBV had IP10\/MIG\u2010positive H&amp;RS cells. The chemokine expressions in H&amp;RS cells seemed to be associated with EBV infection rather than histologic subtypes. In the DNA chip expression analysis, classical HL and HL\u2010like ATLL had a mixed Th1\/Th2\u2010type profile, and HL MC (EBV\u2010positive) and HL NS (EBV\u2010negative) were differentially clustered. However, 2 cases of HL\u2010like ATLL clustered with HL MS and the other 2 cases of HL\u2010like ATLL clustered with HL NS. The former HL\u2010like ATLL had EBV infection in H&amp;RS cells, whereas the latter did not have EBV infection. This finding also suggests that EBV might influence local expression of chemokines rather than HL subtypes. Our results indicate that local immunologic disorder or imbalance appears to influence the formation of H&amp;RS cells and that in HL\u2010like ATLL, HTLV\u20101 infection might not be necessary for H&amp;RS cell formation. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.11301","type":"journal-article","created":{"date-parts":[[2003,7,11]],"date-time":"2003-07-11T10:07:05Z","timestamp":1057918025000},"page":"706-712","source":"Crossref","is-referenced-by-count":27,"title":["Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: Classical Hodgkin lymphoma <i>vs.<\/i> Hodgkin\u2010like ATLL"],"prefix":"10.1002","volume":"106","author":[{"given":"Koichi","family":"Ohshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Suefuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tutiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Suzumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,6,9]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1495"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.471"},{"key":"e_1_2_5_4_2","first-page":"351","article-title":"The nature of the lymphocytes surrounding Reed\u2010Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease","volume":"135","author":"Poppema S","year":"1989","journal-title":"Am J Pathol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/9.suppl_5.S21"},{"key":"e_1_2_5_6_2","first-page":"1","article-title":"Adult T\u2010cell leukemia and HTLV\u2010I related diseases","volume":"39","author":"Takatsuki K","year":"1992","journal-title":"Gann Mono Cancer Res"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910315)67:6<1622::AID-CNCR2820670625>3.0.CO;2-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<592::AID-IJC7>3.0.CO;2-L"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.3.909"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/33340"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.8.2463"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65424-7"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880473"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5235.467"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<868::AID-IJC16>3.0.CO;2-W"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.12.1939"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10218"},{"key":"e_1_2_5_18_2","first-page":"173","article-title":"A simplified method of detection of clonal rearrangements of the T\u2010cell receptor\u2010\u03b3 chain gene","volume":"1","author":"McCarthy K","year":"1992","journal-title":"Diagn Mol Pathol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood.V86.10.3930.bloodjournal86103930","article-title":"Analysis of rearranged T\u2010cell receptor \u03b2\u2010chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis","volume":"86","author":"Kneda M","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3080.3080"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(99)03014-1"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510053331403"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059218"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)84661-0"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620103"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4099"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000082984"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.2065"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1543"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1505"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01214.x"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.11301","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.11301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:45:46Z","timestamp":1697222746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.11301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9,20]]}},"alternative-id":["10.1002\/ijc.11301"],"URL":"https:\/\/doi.org\/10.1002\/ijc.11301","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,9]]}}}